Drug Database
Back to search

United States· US:70954-959_b95c6668-cf33-4623-bcf0-02f8b4a51719

Methenamine Hippurate

A medicinal product containing methenamine hippurate, registered in United States by ANI Pharmaceuticals, Inc..

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedMethenamine HippurateATC—REGISTER NO.US:70954-959_b95c6668…PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about methenamine hippurateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
METHENAMINE HIPPURATE
Manufacturer
ANI Pharmaceuticals, Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    70954-959-10

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Methenamine hippurate in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methenamine hippurate products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Belgium · Vesaphir
  • Germany · Cystohipp
  • Denmark · Haiprex, Methenamine Hippurate Eql Pharma
  • Finland · Hiprex, Methenamine Hippurate Orion
  • France · Altaromin
  • United Kingdom (Northern Ireland) · Hiprex, Methenamine Hippurate Brown & Burk Uk
  • Ireland · Methenamine Hippurate Brown & Burk
  • Iceland · Haiprex
  • Luxembourg · Vesaphir
  • Malta · Methenamine Hippurate Brown & Burk, Methenamine Hippurate Eql Pharma
  • Netherlands · Vesaphir
  • Norway · Hiprex, Methenamine Hippurate Eql Pharma
  • Sweden · Hiprex, Methenamine Hippurate Brown & Burk

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e7f071f3-a5ce-46da-b214-277aa143ccb6
GET /v1/drugs/e7f071f3-a5ce-46da-b214-277aa143ccb6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "1",
  "substance": "METHENAMINE HIPPURATE",
  "productndc": "70954-959",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "g/1",
  "application_number": "NDA017681",
  "marketing_category": "NDA"
}
API referenceMCP serverPlans

See everything about methenamine hippurate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console